ArticleIndian journal of clinical biochemistry : IJCB2024
Study of Glabranin as an Inhibitor Against Prostate Cancer: Molecular Docking, Molecular Dynamics Simulation, MM-PBSA Calculation and QSAR Prediction.
Rene Barbie Browne et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.